AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LONDON, GREATER LONDON, UNITED KINGDOM, February 17, 2025 /EINPresswire.com/ -- Have you considered the growth trajectory of the rotavirus vaccine market?
In recent years, the rotavirus vaccine market has grown rapidly, expanding from $9.18 billion in 2024 to a projected $10.14 billion in 2025, displaying a compound annual growth rate CAGR of 10.5%. Key contributors to this evident growth include rising awareness of rotavirus, improved healthcare infrastructure, government immunization initiatives, and escalating incidence rates of rotavirus infections.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp
A forward projection reveals that the rotavirus vaccine market size is poised for rapid growth in the next few years, expanding to a staggering $14.96 billion in 2029 at a CAGR of 10.2%. Driving this considerable market expansion are potential factors such as rising birth rates, an aggressive expansion of vaccination programs, a strong societal focus on preventive healthcare, economic growth and improved access to healthcare, as well as supportive government policies and funding. Additionally, prevailing trends likely to shape the market in the forecast period encompass advancements in vaccine and oral-dosing technologies, improved vaccine formulations, integration of combination vaccines and digital health.
What Drives The Rotavirus vaccine Market Growth?
With the global birth rates expected to rise, one can predict a correlating growth in the rotavirus vaccine market. Birth rates, a measure of the number of live births per 1,000 people in a population over a specific period, are often influenced by higher economic stability and growth, paired with supportive policies such as parental leave, child benefits, and childcare subsidies. Considering the effectiveness of rotavirus vaccines in reducing the incidence of severe rotavirus gastroenteritis in infants, their increased use can positively impinge on child health outcomes while cutting healthcare costs associated with rotavirus infections.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report
Who Are The Key Players In The Rotavirus vaccine Market?
The key industry players currently shaping the rotavirus vaccine market include internationally recognized companies such as Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, and Daiichi Sankyo Company Limited, among others. A rising trend in this specialized market involves these major companies adopting oral-dosing applicators to boost vaccine delivery efficiency and promote patient compliance. Notably, such oral-dosing applicators are uniquely designed to administer liquid medications or vaccines directly into the patient's mouth, ensuring accuracy in dosage and ease of use, particularly for infants and young children.
How Is The Rotavirus vaccine Market Segmented?
Structured by type, the rotavirus vaccine market report categorically segments the market into Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, and Other Types. Further segmenting these categories under sub-segments such as dosing schedule and administration, efficacy and safety profile, and target demographics offers a more detailed insight into the market. The report also segments by application Adult or Pediatric and by end-users Hospitals, Clinics, Academic Research.
What is the Regional Analysis Of Rotavirus vaccine Market?
In terms of regional trends, North America set the pace as the largest region in the rotavirus vaccine market in 2024. However, an expected shift is anticipated as Asia-Pacific rises to emerge as the fastest-growing region in the forecast period. The extensive report covers insights into a multitude of regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse for more similar reports-
Meningococcal Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Swine Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report
The Business Research Company has earned a reputation for comprehensive, data-rich research and insights, with more than 15,000 reports from 27 industries covering over 60 geographies. We are armed with 1,500,000 datasets, offer in-depth secondary research, and provide unique insights from industry leaders to give you the information you need to stay ahead in the game.
Connect with us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Drop us a mail at [email protected]
Keep an eye on us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
